NitricBio turns to Clinipace Worldwide to manage several dermatology clinical trials
Tuesday, January 12th, 2010Welcome to our newest client! NitricBio has selected the company to manage and deploy multiple studies in support of medical applications of topical nitric oxide gas (gNO).
NitricBio is a mid-stage specialty pharmaceutical company focused on the dermatology and podiatry markets, with two unique drug delivery technologies. The company awarded Clinipace Worldwide a four-project engagement, including data management, statistical services, and medical writing for two phase 2 trials as well as providing fully-integrated clinical research services to manage and conduct two phase 3 trials.
Read the full release.
